134 related articles for article (PubMed ID: 36519745)
1. Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients.
Pereira-Veiga T; Bravo S; Gómez-Tato A; Yáñez-Gómez C; Abuín C; Varela V; Cueva J; Palacios P; Dávila-Ibáñez AB; Piñeiro R; Vilar A; Chantada-Vázquez MDP; López-López R; Costa C
Mol Cell Proteomics; 2022 Dec; 21(12):100435. PubMed ID: 36519745
[TBL] [Abstract][Full Text] [Related]
2. Heterotypic clustering of circulating tumor cells and circulating cancer-associated fibroblasts facilitates breast cancer metastasis.
Sharma U; Medina-Saenz K; Miller PC; Troness B; Spartz A; Sandoval-Leon A; Parke DN; Seagroves TN; Lippman ME; El-Ashry D
Breast Cancer Res Treat; 2021 Aug; 189(1):63-80. PubMed ID: 34216317
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis.
Ramirez AB; Bhat R; Sahay D; De Angelis C; Thangavel H; Hedayatpour S; Dobrolecki LE; Nardone A; Giuliano M; Nagi C; Rimawi M; Osborne CK; Lewis MT; Stilwell JL; Kaldjian EP; Schiff R; Trivedi MV
BMC Cancer; 2019 Mar; 19(1):220. PubMed ID: 30871481
[TBL] [Abstract][Full Text] [Related]
4. Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
Todenhöfer T; Hennenlotter J; Dorner N; Kühs U; Aufderklamm S; Rausch S; Bier S; Mischinger J; Schellbach D; Hauch S; Feniuk N; Bedke J; Gakis G; Stenzl A; Schwentner C
J Cancer Res Clin Oncol; 2016 May; 142(5):1013-20. PubMed ID: 26910601
[TBL] [Abstract][Full Text] [Related]
5. A disintegrin and metalloprotease 23 hypermethylation predicts decreased disease-free survival in low-risk breast cancer patients.
Zmetakova I; Kalinkova L; Smolkova B; Horvathova Kajabova V; Cierna Z; Danihel L; Bohac M; Sedlackova T; Minarik G; Karaba M; Benca J; Cihova M; Buocikova V; Miklikova S; Mego M; Fridrichova I
Cancer Sci; 2019 May; 110(5):1695-1704. PubMed ID: 30815959
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients.
Aktas B; Kasimir-Bauer S; Müller V; Janni W; Fehm T; Wallwiener D; Pantel K; Tewes M;
BMC Cancer; 2016 Jul; 16():522. PubMed ID: 27456970
[TBL] [Abstract][Full Text] [Related]
7. Gene signatures of circulating breast cancer cell models are a source of novel molecular determinants of metastasis and improve circulating tumor cell detection in patients.
Fina E; Cleris L; Dugo M; Lecchi M; Ciniselli CM; Lecis D; Bianchi GV; Verderio P; Daidone MG; Cappelletti V
J Exp Clin Cancer Res; 2022 Feb; 41(1):78. PubMed ID: 35216615
[TBL] [Abstract][Full Text] [Related]
8. Increased expression levels of WAVE3 are associated with the progression and metastasis of triple negative breast cancer.
Kulkarni S; Augoff K; Rivera L; McCue B; Khoury T; Groman A; Zhang L; Tian L; Sossey-Alaoui K
PLoS One; 2012; 7(8):e42895. PubMed ID: 22952619
[TBL] [Abstract][Full Text] [Related]
9. FOXD1-dependent RalA-ANXA2-Src complex promotes CTC formation in breast cancer.
Long Y; Chong T; Lyu X; Chen L; Luo X; Faleti OD; Deng S; Wang F; He M; Qian Z; Zhao H; Zhou W; Guo X; Chen C; Li X
J Exp Clin Cancer Res; 2022 Oct; 41(1):301. PubMed ID: 36229838
[TBL] [Abstract][Full Text] [Related]
10. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
[TBL] [Abstract][Full Text] [Related]
11. Circulating Tumor Cells Exhibit Metastatic Tropism and Reveal Brain Metastasis Drivers.
Klotz R; Thomas A; Teng T; Han SM; Iriondo O; Li L; Restrepo-Vassalli S; Wang A; Izadian N; MacKay M; Moon BS; Liu KJ; Ganesan SK; Lee G; Kang DS; Walmsley CS; Pinto C; Press MF; Lu W; Lu J; Juric D; Bardia A; Hicks J; Salhia B; Attenello F; Smith AD; Yu M
Cancer Discov; 2020 Jan; 10(1):86-103. PubMed ID: 31601552
[TBL] [Abstract][Full Text] [Related]
12. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-to-mesenchymal transition of tumor cells: cancer progression and metastasis.
Vardas V; Politaki E; Pantazaka E; Georgoulias V; Kallergi G
Int J Dev Biol; 2022; 66(1-2-3):277-283. PubMed ID: 34881791
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the diagnostic value of circulating tumor cells with CytoSorter
Jin L; Zhao W; Zhang J; Chen W; Xie T; Wang L; Fan W; Xie S; Shen J; Zheng H; Hu W; Wei Q; Dong M; Wang Q; Shen J; Liu Y
Cancer Med; 2020 Mar; 9(5):1638-1647. PubMed ID: 31908156
[TBL] [Abstract][Full Text] [Related]
15. Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
Dwedar FI; Shams-Eldin RS; Nayer Mohamed S; Mohammed AF; Gomaa SH
J Clin Lab Anal; 2021 Aug; 35(8):e23887. PubMed ID: 34264524
[TBL] [Abstract][Full Text] [Related]
16. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
[TBL] [Abstract][Full Text] [Related]
17. Beta 2-Adrenergic Receptor in Circulating Cancer-Associated Cells Predicts for Increases in Stromal Macrophages in Circulation and Patient Survival in Metastatic Breast Cancer.
Gardner KP; Cristofanilli M; Chumsri S; Lapidus R; Tang CM; Raghavakaimal A; Adams DL
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806301
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer.
Cierna Z; Mego M; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Cingelova S; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2014 Jun; 14():472. PubMed ID: 24972610
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progression.
Skerenova M; Mikulova V; Capoun O; Zima T; Tesarova P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):272-280. PubMed ID: 28529342
[TBL] [Abstract][Full Text] [Related]
20. Multiple biomarker expression on circulating tumor cells in comparison to tumor tissues from primary and metastatic sites in patients with locally advanced/inflammatory, and stage IV breast cancer, using a novel detection technology.
Somlo G; Lau SK; Frankel P; Hsieh HB; Liu X; Yang L; Krivacic R; Bruce RH
Breast Cancer Res Treat; 2011 Jul; 128(1):155-63. PubMed ID: 21499685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]